MA27172A1 - 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments - Google Patents

3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Info

Publication number
MA27172A1
MA27172A1 MA27803A MA27803A MA27172A1 MA 27172 A1 MA27172 A1 MA 27172A1 MA 27803 A MA27803 A MA 27803A MA 27803 A MA27803 A MA 27803A MA 27172 A1 MA27172 A1 MA 27172A1
Authority
MA
Morocco
Prior art keywords
oxdiazol
alcoxy
medicines
phenyl
production
Prior art date
Application number
MA27803A
Other languages
English (en)
French (fr)
Inventor
Karl Schoenafinger
Stefan Petry
Gunter Muller
Armin Bauer
Hubert Ott Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27172A1 publication Critical patent/MA27172A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
MA27803A 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments MA27172A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
MA27172A1 true MA27172A1 (fr) 2005-01-03

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27803A MA27172A1 (fr) 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (enExample)
JP (1) JP4486363B2 (enExample)
KR (1) KR20040095240A (enExample)
CN (1) CN1639137A (enExample)
AR (1) AR038701A1 (enExample)
AT (1) ATE557012T1 (enExample)
AU (1) AU2003226977A1 (enExample)
BR (1) BR0307921A (enExample)
CA (1) CA2477031A1 (enExample)
CO (1) CO5611146A2 (enExample)
DE (1) DE10208987A1 (enExample)
HR (1) HRP20040782A2 (enExample)
HU (1) HUP0402671A3 (enExample)
IL (1) IL163683A0 (enExample)
MA (1) MA27172A1 (enExample)
MX (1) MXPA04007960A (enExample)
NO (1) NO20044090L (enExample)
PE (1) PE20030928A1 (enExample)
PL (1) PL370423A1 (enExample)
RU (1) RU2004128933A (enExample)
TW (1) TW200400951A (enExample)
WO (1) WO2003072555A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
CA2585175A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
CA2710743A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Ca., S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2001066531A1 (de) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one (und) ihre verwendung zur hemmung der hormonsensitiven lipase

Also Published As

Publication number Publication date
HRP20040782A2 (en) 2005-02-28
NO20044090L (no) 2004-11-04
PE20030928A1 (es) 2003-12-17
EP1480960B1 (de) 2012-05-09
EP1480960A1 (de) 2004-12-01
AU2003226977A1 (en) 2003-09-09
AR038701A1 (es) 2005-01-26
JP4486363B2 (ja) 2010-06-23
CO5611146A2 (es) 2006-02-28
KR20040095240A (ko) 2004-11-12
CN1639137A (zh) 2005-07-13
RU2004128933A (ru) 2005-04-20
BR0307921A (pt) 2004-12-21
MXPA04007960A (es) 2004-11-26
ATE557012T1 (de) 2012-05-15
TW200400951A (en) 2004-01-16
IL163683A0 (en) 2005-12-18
HUP0402671A2 (hu) 2005-04-28
WO2003072555A1 (de) 2003-09-04
CA2477031A1 (en) 2003-09-04
DE10208987A1 (de) 2003-09-11
JP2005519085A (ja) 2005-06-30
HUP0402671A3 (en) 2006-07-28
PL370423A1 (en) 2005-05-30

Similar Documents

Publication Publication Date Title
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
CY2015009PI2 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
SI1667993T1 (sl) Heteroarilno substituirani 1,3-dihidroindol-2-onski derivati in zdravila, ki jih vsebujejo
SI1532149T1 (sl) amino piperidin il ksantini njihova priprava in njihova uporaba kot zdravila
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
IS7564A (is) Lyfjablanda með breytta losun
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
EP1624935A4 (en) ANTI-ADHESION COMPOUNDS AND USE METHOD THEREFOR
PL344467A1 (en) Substituted indolinones, the production thereof and their use as medicaments
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
IL149400A0 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
EP1750693A4 (en) OKULOSELECTIVE MEDICINAL PRODUCTS AND PRODRUGS
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments
FR2870539B1 (fr) Nouvelles methodes et medicaments
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
ATE487741T1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
ATE405275T1 (de) Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
EP1745000A4 (en) NEW ANTHRACHINONE, MANUFACTURING METHOD AND USE THEREOF